-
1
-
-
0033850407
-
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
-
Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR: Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33(1), 95-130 (2000).
-
(2000)
Brain Res. Brain Res. Rev
, vol.33
, Issue.1
, pp. 95-130
-
-
Buee, L.1
Bussiere, T.2
Buee-Scherrer, V.3
Delacourte, A.4
Hof, P.R.5
-
2
-
-
13944278863
-
A common inversion under selection in Europeans
-
Stefansson H, Helgason A, Thorleifsson G et al.: A common inversion under selection in Europeans. Nat. Genet. 37(2), 129-137 (2005).
-
(2005)
Nat. Genet
, vol.37
, Issue.2
, pp. 129-137
-
-
Stefansson, H.1
Helgason, A.2
Thorleifsson, G.3
-
3
-
-
1842419456
-
Microtubule-associated protein tau gene: A risk factor in human neurodegenerative diseases
-
Schraen-Maschke S, Dhaenens CM, Delacourte A, Sablonniere B: Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases. Neurobiol. Dis. 15(3), 449-460 (2004).
-
(2004)
Neurobiol. Dis
, vol.15
, Issue.3
, pp. 449-460
-
-
Schraen-Maschke, S.1
Dhaenens, C.M.2
Delacourte, A.3
Sablonniere, B.4
-
4
-
-
3042813452
-
The structure of the tau haplotype in controls and in progressive supranuclear palsy
-
Pittman AM, Myers AJ, Duckworth J et al.: The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum. Mol. Genet. 13(12), 1267-1274 (2004).
-
(2004)
Hum. Mol. Genet
, vol.13
, Issue.12
, pp. 1267-1274
-
-
Pittman, A.M.1
Myers, A.J.2
Duckworth, J.3
-
5
-
-
0028853922
-
Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes
-
LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI: Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl Acad. Sci. USA 92(22), 10369-10373 (1995).
-
(1995)
Proc. Natl Acad. Sci. USA
, vol.92
, Issue.22
, pp. 10369-10373
-
-
LoPresti, P.1
Szuchet, S.2
Papasozomenos, S.C.3
Zinkowski, R.P.4
Binder, L.I.5
-
6
-
-
10944272640
-
Tau gene alternative splicing: Expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases
-
Andreadis A: Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta 1739(2-3), 91-103 (2005).
-
(2005)
Biochim. Biophys. Acta
, vol.1739
, Issue.2-3
, pp. 91-103
-
-
Andreadis, A.1
-
7
-
-
34447124582
-
RNA and protein-dependent mechanisms in Tauopathies: Consequences for therapeutic strategies
-
Gallo JM, Noble W, Martin TR: RNA and protein-dependent mechanisms in Tauopathies: consequences for therapeutic strategies. Cell. Mol. Life Sci. 64(13), 1701-1714 (2007).
-
(2007)
Cell. Mol. Life Sci
, vol.64
, Issue.13
, pp. 1701-1714
-
-
Gallo, J.M.1
Noble, W.2
Martin, T.R.3
-
8
-
-
43249124363
-
Microtubule-associated protein Tau in development, degeneration and protection of neurons
-
Wang JZ, Liu F: Microtubule-associated protein Tau in development, degeneration and protection of neurons. Prog. Neurobiol. 85(2), 148-175 (2008).
-
(2008)
Prog. Neurobiol
, vol.85
, Issue.2
, pp. 148-175
-
-
Wang, J.Z.1
Liu, F.2
-
9
-
-
27844470590
-
Molecular motors implicated in the axonal transport of Tau and α-synuclein
-
Utton MA, Noble WJ, Hill JE, Anderton BH, Hanger DP: Molecular motors implicated in the axonal transport of Tau and α-synuclein. J. Cell. Sci. 118(Pt 20), 4645-4654 (2005).
-
(2005)
J. Cell. Sci
, vol.118
, Issue.PART 20
, pp. 4645-4654
-
-
Utton, M.A.1
Noble, W.J.2
Hill, J.E.3
Anderton, B.H.4
Hanger, D.P.5
-
10
-
-
35649028013
-
Interaction of Tau protein with the dynactin complex
-
Magnani E, Fan J, Gasparini L et al.: Interaction of Tau protein with the dynactin complex. EMBO J. 26(21), 4546-4554 (2007).
-
(2007)
EMBO J
, vol.26
, Issue.21
, pp. 4546-4554
-
-
Magnani, E.1
Fan, J.2
Gasparini, L.3
-
11
-
-
49649119504
-
Phosphorylation regulates Tau interactions with SH3 domains of phosphatidylinositol-3-kinase, phospholipase Cγ 1, GRB2 and SRC-family kinases
-
Reynolds CH, Garwood CJ, Wray S et al.: Phosphorylation regulates Tau interactions with SH3 domains of phosphatidylinositol-3-kinase, phospholipase Cγ 1, GRB2 and SRC-family kinases. J. Biol. Chem. 283(26), 18177-18186 (2008).
-
(2008)
J. Biol. Chem
, vol.283
, Issue.26
, pp. 18177-18186
-
-
Reynolds, C.H.1
Garwood, C.J.2
Wray, S.3
-
12
-
-
0036469248
-
Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein Tau
-
Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J: Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein Tau. J. Neurosci. 22(3), 698-707 (2002).
-
(2002)
J. Neurosci
, vol.22
, Issue.3
, pp. 698-707
-
-
Klein, C.1
Kramer, E.M.2
Cardine, A.M.3
Schraven, B.4
Brandt, R.5
Trotter, J.6
-
13
-
-
46749151737
-
Tau isoform expression and regulation in human cortical neurons
-
Deshpande A, Win KM, Busciglio J: Tau isoform expression and regulation in human cortical neurons. Faseb J. 22(7), 2357-2367 (2008).
-
(2008)
Faseb J
, vol.22
, Issue.7
, pp. 2357-2367
-
-
Deshpande, A.1
Win, K.M.2
Busciglio, J.3
-
14
-
-
0024745894
-
Multiple isoforms of human microtubule-associated protein Tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
-
Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA: Multiple isoforms of human microtubule-associated protein Tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3(4), 519-526 (1989).
-
(1989)
Neuron
, vol.3
, Issue.4
, pp. 519-526
-
-
Goedert, M.1
Spillantini, M.G.2
Jakes, R.3
Rutherford, D.4
Crowther, R.A.5
-
15
-
-
34548191034
-
Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
-
Hanger DP, Byers HL, Wray S et al.: Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 282(32), 23645-23654 (2007).
-
(2007)
J. Biol. Chem
, vol.282
, Issue.32
, pp. 23645-23654
-
-
Hanger, D.P.1
Byers, H.L.2
Wray, S.3
-
16
-
-
43449128899
-
-
Sergeant N, Bretteville A, Hamdane M et al.: Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics 5(2), 207-224 (2008).
-
Sergeant N, Bretteville A, Hamdane M et al.: Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics 5(2), 207-224 (2008).
-
-
-
-
17
-
-
10944223484
-
Tau protein as a differential biomarker of tauopathies
-
Sergeant N, Delacourte A, Buee L: Tau protein as a differential biomarker of tauopathies. Biochim. Biophys. Acta 1739(2-3), 179-197 (2005).
-
(2005)
Biochim. Biophys. Acta
, vol.1739
, Issue.2-3
, pp. 179-197
-
-
Sergeant, N.1
Delacourte, A.2
Buee, L.3
-
18
-
-
5444273804
-
MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons
-
Mandelkow EM, Thies E, Trinczek B, Biernat J, Mandelkow E: MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J. Cell Biol. 167(1), 99-110 (2004).
-
(2004)
J. Cell Biol
, vol.167
, Issue.1
, pp. 99-110
-
-
Mandelkow, E.M.1
Thies, E.2
Trinczek, B.3
Biernat, J.4
Mandelkow, E.5
-
19
-
-
12144288564
-
Phosphorylation of Tau by fyn: Implications for Alzheimer's disease
-
Lee G, Thangavel R, Sharma VM et al.: Phosphorylation of Tau by fyn: implications for Alzheimer's disease. J. Neurosci. 24(9), 2304-2312 (2004).
-
(2004)
J. Neurosci
, vol.24
, Issue.9
, pp. 2304-2312
-
-
Lee, G.1
Thangavel, R.2
Sharma, V.M.3
-
20
-
-
0036138048
-
Rapid tyrosine phosphorylation of neuronal proteins including Tau and focal adhesion kinase in response to amyloid-β peptide exposure: Involvement of Src family protein kinases
-
Williamson R, Scales T, Clark BR et al.: Rapid tyrosine phosphorylation of neuronal proteins including Tau and focal adhesion kinase in response to amyloid-β peptide exposure: involvement of Src family protein kinases. J. Neurosci. 22(1), 10-20 (2002).
-
(2002)
J. Neurosci
, vol.22
, Issue.1
, pp. 10-20
-
-
Williamson, R.1
Scales, T.2
Clark, B.R.3
-
21
-
-
22244475384
-
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament Tau and in fetal Tau with c-Abl as the candidate tyrosine kinase
-
Derkinderen P, Scales TM, Hanger DP et al.: Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament Tau and in fetal Tau with c-Abl as the candidate tyrosine kinase. J. Neurosci. 25(28), 6584-6593 (2005).
-
(2005)
J. Neurosci
, vol.25
, Issue.28
, pp. 6584-6593
-
-
Derkinderen, P.1
Scales, T.M.2
Hanger, D.P.3
-
22
-
-
33748323156
-
A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism
-
Koolen DA, Vissers LE, Pfundt R et al.: A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat. Genet. 38(9), 999-1001 (2006).
-
(2006)
Nat. Genet
, vol.38
, Issue.9
, pp. 999-1001
-
-
Koolen, D.A.1
Vissers, L.E.2
Pfundt, R.3
-
23
-
-
33748333194
-
Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome
-
Sharp AJ, Hansen S, Selzer RR et al.: Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat. Genet. 38(9), 1038-1042 (2006).
-
(2006)
Nat. Genet
, vol.38
, Issue.9
, pp. 1038-1042
-
-
Sharp, A.J.1
Hansen, S.2
Selzer, R.R.3
-
24
-
-
33744987916
-
A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient
-
Varela MC, Krepischi-Santos AC, Paz JA et al.: A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient. Cytogenet. Genome Res. 114(1), 89-92 (2006).
-
(2006)
Cytogenet. Genome Res
, vol.114
, Issue.1
, pp. 89-92
-
-
Varela, M.C.1
Krepischi-Santos, A.C.2
Paz, J.A.3
-
25
-
-
33748300645
-
Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability
-
Shaw-Smith C, Pittman AM, Willatt L et al.: Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat. Genet. 38(9), 1032-1037 (2006).
-
(2006)
Nat. Genet
, vol.38
, Issue.9
, pp. 1032-1037
-
-
Shaw-Smith, C.1
Pittman, A.M.2
Willatt, L.3
-
26
-
-
34447309023
-
A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features
-
Kirchhoff M, Bisgaard AM, Duno M, Hansen FJ, Schwartz M: A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features. Eur. J. Med. Genet. 50(4), 256-263 (2007).
-
(2007)
Eur. J. Med. Genet
, vol.50
, Issue.4
, pp. 256-263
-
-
Kirchhoff, M.1
Bisgaard, A.M.2
Duno, M.3
Hansen, F.J.4
Schwartz, M.5
-
27
-
-
33847103297
-
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
-
Wszolek ZK, Tsuboi Y, Ghetti B, Pickering-Brown S, Baba Y, Cheshire WP: Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Orphanet J. Rare Dis. 1, 30 (2006).
-
(2006)
Orphanet J. Rare Dis
, vol.1
, pp. 30
-
-
Wszolek, Z.K.1
Tsuboi, Y.2
Ghetti, B.3
Pickering-Brown, S.4
Baba, Y.5
Cheshire, W.P.6
-
28
-
-
42249085980
-
Refining frontotemporal dementia with parkinsonism linked to chromosome 17: Introducing FTDP-17 (MAPT) and FTDP-17 (PGRN)
-
Boeve BF, Hutton M: Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch. Neurol. 65(4), 460-464 (2008).
-
(2008)
Arch. Neurol
, vol.65
, Issue.4
, pp. 460-464
-
-
Boeve, B.F.1
Hutton, M.2
-
29
-
-
34250335127
-
Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology
-
Caffrey TM, Wade-Martins R: Functional MAPT haplotypes: bridging the gap between genotype and neuropathology. Neurobiol. Dis. 27(1), 1-10 (2007).
-
(2007)
Neurobiol. Dis
, vol.27
, Issue.1
, pp. 1-10
-
-
Caffrey, T.M.1
Wade-Martins, R.2
-
30
-
-
48249102700
-
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study
-
Tobin JE, Latourelle JC, Lew MF et al.: Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology 71(1), 28-34 (2008).
-
(2008)
Neurology
, vol.71
, Issue.1
, pp. 28-34
-
-
Tobin, J.E.1
Latourelle, J.C.2
Lew, M.F.3
-
31
-
-
35148829539
-
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease
-
Zabetian CP, Hutter CM, Factor SA et al.: Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann. Neurol. 62(2), 137-144 (2007).
-
(2007)
Ann. Neurol
, vol.62
, Issue.2
, pp. 137-144
-
-
Zabetian, C.P.1
Hutter, C.M.2
Factor, S.A.3
-
32
-
-
24644502474
-
Linkage disequilibrium fine mapping and haplotype association analysis of the Tau gene in progressive supranuclear palsy and corticobasal degeneration
-
Pittman AM, Myers AJ, Abou-Sleiman P et al.: Linkage disequilibrium fine mapping and haplotype association analysis of the Tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet. 42(11), 837-846 (2005).
-
(2005)
J. Med. Genet
, vol.42
, Issue.11
, pp. 837-846
-
-
Pittman, A.M.1
Myers, A.J.2
Abou-Sleiman, P.3
-
33
-
-
26444463460
-
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease
-
Myers AJ, Kaleem M, Marlowe L et al.: The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum. Mol. Genet. 14(16), 2399-2404 (2005).
-
(2005)
Hum. Mol. Genet
, vol.14
, Issue.16
, pp. 2399-2404
-
-
Myers, A.J.1
Kaleem, M.2
Marlowe, L.3
-
34
-
-
33749499157
-
HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, Tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin
-
Mukherjee O, Pastor P, Cairns NJ et al.: HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, Tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann. Neurol. 60(3), 314-322 (2006).
-
(2006)
Ann. Neurol
, vol.60
, Issue.3
, pp. 314-322
-
-
Mukherjee, O.1
Pastor, P.2
Cairns, N.J.3
-
35
-
-
27744488802
-
High-density SNP haplotyping suggests altered regulation of Tau gene expression in progressive supranuclear palsy
-
Rademakers R, Melquist S, Cruts M et al.: High-density SNP haplotyping suggests altered regulation of Tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet. 14(21), 3281-3292 (2005).
-
(2005)
Hum. Mol. Genet
, vol.14
, Issue.21
, pp. 3281-3292
-
-
Rademakers, R.1
Melquist, S.2
Cruts, M.3
-
36
-
-
54849415264
-
The effect of age and the H1c MAPT haplotype on MAPT expression in human brain
-
Hayesmoore JB, Bray NJ, Cross WC, Owen MJ, O'Donovan MC, Morris HR: The effect of age and the H1c MAPT haplotype on MAPT expression in human brain. Neurobiol. Aging (2008)
-
(2008)
Neurobiol. Aging
-
-
Hayesmoore, J.B.1
Bray, N.J.2
Cross, W.C.3
Owen, M.J.4
O'Donovan, M.C.5
Morris, H.R.6
-
37
-
-
33847178181
-
The MAPT H1c risk haplotype is associated with increased expression of Tau and especially of 4 repeat containing transcripts
-
Myers AJ, Pittman AM, Zhao AS et al.: The MAPT H1c risk haplotype is associated with increased expression of Tau and especially of 4 repeat containing transcripts. Neurobiol. Dis. 25(3), 561-570 (2007).
-
(2007)
Neurobiol. Dis
, vol.25
, Issue.3
, pp. 561-570
-
-
Myers, A.J.1
Pittman, A.M.2
Zhao, A.S.3
-
38
-
-
33845361007
-
Haplotype-specific expression of exon 10 at the human MAPT locus
-
Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R: Haplotype-specific expression of exon 10 at the human MAPT locus. Hum. Mol. Genet. 15(24), 3529-3537 (2006).
-
(2006)
Hum. Mol. Genet
, vol.15
, Issue.24
, pp. 3529-3537
-
-
Caffrey, T.M.1
Joachim, C.2
Paracchini, S.3
Esiri, M.M.4
Wade-Martins, R.5
-
39
-
-
36749028147
-
Brain Tau expression and correlation with the H1/H1 Tau genotype in frontotemporal lobar degeneration patients
-
Llado A, Ezquerra M, Gaig C, Sanchez-Valle R, Tolosa E, Molinuevo JL: Brain Tau expression and correlation with the H1/H1 Tau genotype in frontotemporal lobar degeneration patients. J. Neural Transm. 114(12), 1585-1588 (2007).
-
(2007)
J. Neural Transm
, vol.114
, Issue.12
, pp. 1585-1588
-
-
Llado, A.1
Ezquerra, M.2
Gaig, C.3
Sanchez-Valle, R.4
Tolosa, E.5
Molinuevo, J.L.6
-
40
-
-
35148866228
-
Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease
-
Goris A, Williams-Gray CH, Clark GR et al.: Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann. Neurol. 62(2), 145-153 (2007).
-
(2007)
Ann. Neurol
, vol.62
, Issue.2
, pp. 145-153
-
-
Goris, A.1
Williams-Gray, C.H.2
Clark, G.R.3
-
41
-
-
34548207303
-
Cerebral involvement in myotonic dystrophies
-
Meola G, Sansone V: Cerebral involvement in myotonic dystrophies. Muscle Nerve 36(3), 294-306 (2007).
-
(2007)
Muscle Nerve
, vol.36
, Issue.3
, pp. 294-306
-
-
Meola, G.1
Sansone, V.2
-
42
-
-
33947709394
-
Cognitive impairment in adult myotonic dystrophies: A longitudinal study
-
Sansone V, Gandossini S, Cotelli M, Calabria M, Zanetti O, Meola G: Cognitive impairment in adult myotonic dystrophies: a longitudinal study. Neurol. Sci. 28(1), 9-15 (2007).
-
(2007)
Neurol. Sci
, vol.28
, Issue.1
, pp. 9-15
-
-
Sansone, V.1
Gandossini, S.2
Cotelli, M.3
Calabria, M.4
Zanetti, O.5
Meola, G.6
-
43
-
-
33748373580
-
RNA-mediated neuromuscular disorders
-
Ranum LP, Cooper TA: RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 29, 259-277 (2006).
-
(2006)
Annu. Rev. Neurosci
, vol.29
, pp. 259-277
-
-
Ranum, L.P.1
Cooper, T.A.2
-
44
-
-
0029822936
-
Specific Tau variants in the brains of patients with myotonic dystrophy
-
Vermersch P, Sergeant N, Ruchoux MM et al.: Specific Tau variants in the brains of patients with myotonic dystrophy. Neurology 47(3), 711-717 (1996).
-
(1996)
Neurology
, vol.47
, Issue.3
, pp. 711-717
-
-
Vermersch, P.1
Sergeant, N.2
Ruchoux, M.M.3
-
45
-
-
34548263375
-
Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy
-
Kuyumcu-Martinez NM, Cooper TA: Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. Prog. Mol. Subcell. Biol. 44, 133-159 (2006).
-
(2006)
Prog. Mol. Subcell. Biol
, vol.44
, pp. 133-159
-
-
Kuyumcu-Martinez, N.M.1
Cooper, T.A.2
-
46
-
-
11044233708
-
Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons
-
Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA: Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13(24), 3079-3088 (2004).
-
(2004)
Hum. Mol. Genet
, vol.13
, Issue.24
, pp. 3079-3088
-
-
Jiang, H.1
Mankodi, A.2
Swanson, M.S.3
Moxley, R.T.4
Thornton, C.A.5
-
47
-
-
0034782506
-
Dysregulation of human brain microtubule-associated Tau mRNA maturation in myotonic dystrophy type 1
-
Sergeant N, Sablonniere B, Schraen-Maschke S et al.: Dysregulation of human brain microtubule-associated Tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10(19), 2143-2155 (2001).
-
(2001)
Hum. Mol. Genet
, vol.10
, Issue.19
, pp. 2143-2155
-
-
Sergeant, N.1
Sablonniere, B.2
Schraen-Maschke, S.3
-
48
-
-
28044436700
-
Similar brain Tau pathology in DM2/PROMM and DM1/Steinert disease
-
Maurage CA, Udd B, Ruchoux MM et al.: Similar brain Tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 65(10), 1636-1638 (2005).
-
(2005)
Neurology
, vol.65
, Issue.10
, pp. 1636-1638
-
-
Maurage, C.A.1
Udd, B.2
Ruchoux, M.M.3
-
49
-
-
41349110876
-
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats
-
Dhaenens CM, Schraen-Maschke S, Tran H et al.: Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp. Neurol. 210(2), 467-478 (2008).
-
(2008)
Exp. Neurol
, vol.210
, Issue.2
, pp. 467-478
-
-
Dhaenens, C.M.1
Schraen-Maschke, S.2
Tran, H.3
-
50
-
-
33846318219
-
Myotonic dystrophy: Emerging mechanisms for DM1 and DM2
-
Cho DH, Tapscott SJ: Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim. Biophys. Acta 1772(2), 195-204 (2007).
-
(2007)
Biochim. Biophys. Acta
, vol.1772
, Issue.2
, pp. 195-204
-
-
Cho, D.H.1
Tapscott, S.J.2
-
51
-
-
1342347848
-
Stable-Tau overexpression in human neuroblastoma cells: An open door for explaining neuronal death in tauopathies
-
Delobel P, Mailliot C, Hamdane M et al.: Stable-Tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies. Ann. NY Acad. Sci. 1010, 623-634 (2003).
-
(2003)
Ann. NY Acad. Sci
, vol.1010
, pp. 623-634
-
-
Delobel, P.1
Mailliot, C.2
Hamdane, M.3
-
52
-
-
0036685608
-
Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration
-
Higuchi M, Ishihara T, Zhang B et al.: Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 35(3), 433-446 (2002).
-
(2002)
Neuron
, vol.35
, Issue.3
, pp. 433-446
-
-
Higuchi, M.1
Ishihara, T.2
Zhang, B.3
-
53
-
-
34948883291
-
Increase in the relative expression of Tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains
-
Ingelsson M, Ramasamy K, Russ CB et al.: Increase in the relative expression of Tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Acta Neuropathol. 114(5), 471-479 (2007).
-
(2007)
Acta Neuropathol
, vol.114
, Issue.5
, pp. 471-479
-
-
Ingelsson, M.1
Ramasamy, K.2
Russ, C.B.3
-
54
-
-
33646806069
-
Three-repeat Tau 69 is a major Tau isoform in laser-microdissected Pick bodies
-
Ohkubo T, Sakasegawa Y, Toda H et al.: Three-repeat Tau 69 is a major Tau isoform in laser-microdissected Pick bodies. Amyloid 13(1), 1-5 (2006).
-
(2006)
Amyloid
, vol.13
, Issue.1
, pp. 1-5
-
-
Ohkubo, T.1
Sakasegawa, Y.2
Toda, H.3
-
55
-
-
33645107783
-
The alternative splicing of Tau exon 10 and its regulatory proteins CLK2 and TRA2-β1 changes in sporadic Alzheimer's disease
-
Glatz DC, Rujescu D, Tang Y et al.: The alternative splicing of Tau exon 10 and its regulatory proteins CLK2 and TRA2-β1 changes in sporadic Alzheimer's disease. J. Neurochem. 96(3), 635-644 (2006).
-
(2006)
J. Neurochem
, vol.96
, Issue.3
, pp. 635-644
-
-
Glatz, D.C.1
Rujescu, D.2
Tang, Y.3
-
56
-
-
0038050650
-
Different immunoreactivities of the microtubule-binding region of Tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration
-
Arai T, Ikeda K, Akiyama H et al.: Different immunoreactivities of the microtubule-binding region of Tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 105(5), 489-498 (2003).
-
(2003)
Acta Neuropathol
, vol.105
, Issue.5
, pp. 489-498
-
-
Arai, T.1
Ikeda, K.2
Akiyama, H.3
-
57
-
-
1842451983
-
Alterations in human Tau transcripts correlate with those of neurofilament in sporadic tauopathies
-
Umeda Y, Taniguchi S, Arima K et al.: Alterations in human Tau transcripts correlate with those of neurofilament in sporadic tauopathies. Neurosci. Lett. 359(3), 151-154 (2004).
-
(2004)
Neurosci. Lett
, vol.359
, Issue.3
, pp. 151-154
-
-
Umeda, Y.1
Taniguchi, S.2
Arima, K.3
-
58
-
-
33749152589
-
No alteration in Tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain
-
Ingelsson M, Ramasamy K, Cantuti-Castelvetri I et al.: No alteration in Tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathol. 112(4), 439-449 (2006).
-
(2006)
Acta Neuropathol
, vol.112
, Issue.4
, pp. 439-449
-
-
Ingelsson, M.1
Ramasamy, K.2
Cantuti-Castelvetri, I.3
-
60
-
-
20044367108
-
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human Tau isoforms
-
Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P: Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human Tau isoforms. J. Neurosci. 25(22), 5446-5454 (2005).
-
(2005)
J. Neurosci
, vol.25
, Issue.22
, pp. 5446-5454
-
-
Andorfer, C.1
Acker, C.M.2
Kress, Y.3
Hof, P.R.4
Duff, K.5
Davies, P.6
-
61
-
-
22344438508
-
Tau suppression in a neurodegenerative mouse model improves memory function
-
Santacruz K, Lewis J, Spires T et al.: Tau suppression in a neurodegenerative mouse model improves memory function. Science 309(5733), 476-481 (2005).
-
(2005)
Science
, vol.309
, Issue.5733
, pp. 476-481
-
-
Santacruz, K.1
Lewis, J.2
Spires, T.3
-
62
-
-
17044435830
-
Tau phosphorylation in Alzheimer's disease: Pathogen or protector?
-
Lee HG, Perry G, Moreira PI et al.: Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol. Med. 11(4), 164-169 (2005).
-
(2005)
Trends Mol. Med
, vol.11
, Issue.4
, pp. 164-169
-
-
Lee, H.G.1
Perry, G.2
Moreira, P.I.3
-
63
-
-
7244236320
-
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
-
Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S: Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431(7010), 805-810 (2004).
-
(2004)
Nature
, vol.431
, Issue.7010
, pp. 805-810
-
-
Arrasate, M.1
Mitra, S.2
Schweitzer, E.S.3
Segal, M.R.4
Finkbeiner, S.5
-
64
-
-
0035958642
-
Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles
-
Wittmann CW, Wszolek MF, Shulman JM et al.: Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293(5530), 711-714 (2001).
-
(2001)
Science
, vol.293
, Issue.5530
, pp. 711-714
-
-
Wittmann, C.W.1
Wszolek, M.F.2
Shulman, J.M.3
-
65
-
-
13644268449
-
Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice
-
Terwel D, Lasrado R, Snauwaert J et al.: Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J. Biol. Chem. 280(5), 3963-3973 (2005).
-
(2005)
J. Biol. Chem
, vol.280
, Issue.5
, pp. 3963-3973
-
-
Terwel, D.1
Lasrado, R.2
Snauwaert, J.3
-
66
-
-
44849144122
-
I1PP2A affects Tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A
-
Chen S, Li B, Grundke-Iqbal I, Iqbal K: I1PP2A affects Tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A. J. Biol. Chem. 283(16), 10513-10521 (2008).
-
(2008)
J. Biol. Chem
, vol.283
, Issue.16
, pp. 10513-10521
-
-
Chen, S.1
Li, B.2
Grundke-Iqbal, I.3
Iqbal, K.4
-
67
-
-
0036937699
-
Specific Tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
-
Augustinack JC, Schneider A, Mandelkow EM, Hyman BT: Specific Tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103(1), 26-35 (2002).
-
(2002)
Acta Neuropathol
, vol.103
, Issue.1
, pp. 26-35
-
-
Augustinack, J.C.1
Schneider, A.2
Mandelkow, E.M.3
Hyman, B.T.4
-
68
-
-
33748715165
-
Sequential phosphorylation of Tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope
-
Yoshida H, Goedert M: Sequential phosphorylation of Tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope. J. Neurochem. 99(1), 154-164 (2006).
-
(2006)
J. Neurochem
, vol.99
, Issue.1
, pp. 154-164
-
-
Yoshida, H.1
Goedert, M.2
-
69
-
-
0029670872
-
Specific pathological Tau protein variants characterize Pick's disease
-
Delacourte A, Robitaille Y, Sergeant N et al.: Specific pathological Tau protein variants characterize Pick's disease. J. Neuropathol. Exp. Neurol. 55(2), 159-168 (1996).
-
(1996)
J. Neuropathol. Exp. Neurol
, vol.55
, Issue.2
, pp. 159-168
-
-
Delacourte, A.1
Robitaille, Y.2
Sergeant, N.3
-
70
-
-
0029850476
-
Pick's disease: Hyperphosphorylated Tau protein segregates to the somatoaxonal compartment
-
Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG: Pick's disease: hyperphosphorylated Tau protein segregates to the somatoaxonal compartment. Acta Neuropathol. 92(6), 588-596 (1996).
-
(1996)
Acta Neuropathol
, vol.92
, Issue.6
, pp. 588-596
-
-
Probst, A.1
Tolnay, M.2
Langui, D.3
Goedert, M.4
Spillantini, M.G.5
-
71
-
-
33746652117
-
Alzheimer's disease-like Tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated Tau transgenic mouse without any motor deficits
-
Schindowski K, Bretteville A, Leroy K et al.: Alzheimer's disease-like Tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated Tau transgenic mouse without any motor deficits. Am. J. Pathol. 169(2), 599-616 (2006).
-
(2006)
Am. J. Pathol
, vol.169
, Issue.2
, pp. 599-616
-
-
Schindowski, K.1
Bretteville, A.2
Leroy, K.3
-
72
-
-
0032894121
-
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
-
Delacourte A, David JP, Sergeant N et al.: The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52(6), 1158-1165 (1999).
-
(1999)
Neurology
, vol.52
, Issue.6
, pp. 1158-1165
-
-
Delacourte, A.1
David, J.P.2
Sergeant, N.3
-
73
-
-
1042266624
-
CHIP-Hsc70 complex ubiquitinates phosphorylated Tau and enhances cell survival
-
Shimura H, Schwartz D, Gygi SP, Kosik KS: CHIP-Hsc70 complex ubiquitinates phosphorylated Tau and enhances cell survival. J. Biol. Chem. 279(6), 4869-4876 (2004).
-
(2004)
J. Biol. Chem
, vol.279
, Issue.6
, pp. 4869-4876
-
-
Shimura, H.1
Schwartz, D.2
Gygi, S.P.3
Kosik, K.S.4
-
74
-
-
0033928035
-
The neuronal microtubule-associated protein Tau is a substrate for caspase-3 and an effector of apoptosis
-
Fasulo L, Ugolini G, Visintin M et al.: The neuronal microtubule-associated protein Tau is a substrate for caspase-3 and an effector of apoptosis. J. Neurochem. 75(2), 624-633 (2000).
-
(2000)
J. Neurochem
, vol.75
, Issue.2
, pp. 624-633
-
-
Fasulo, L.1
Ugolini, G.2
Visintin, M.3
-
75
-
-
0041689948
-
Caspase cleavage of Tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
-
Gamblin TC, Chen F, Zambrano A et al.: Caspase cleavage of Tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl Acad. Sci. USA 100(17), 10032-10037 (2003).
-
(2003)
Proc. Natl Acad. Sci. USA
, vol.100
, Issue.17
, pp. 10032-10037
-
-
Gamblin, T.C.1
Chen, F.2
Zambrano, A.3
-
76
-
-
0028785672
-
Calpain-induced proteolysis of normal human Tau and Tau associated with paired helical filaments
-
Yang LS, Ksiezak-Reding H: Calpain-induced proteolysis of normal human Tau and Tau associated with paired helical filaments. Eur. J. Biochem. 233(1), 9-17 (1995).
-
(1995)
Eur. J. Biochem
, vol.233
, Issue.1
, pp. 9-17
-
-
Yang, L.S.1
Ksiezak-Reding, H.2
-
77
-
-
0036789647
-
Proteasomal degradation of Tau protein
-
David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG: Proteasomal degradation of Tau protein. J. Neurochem. 83(1), 176-185 (2002).
-
(2002)
J. Neurochem
, vol.83
, Issue.1
, pp. 176-185
-
-
David, D.C.1
Layfield, R.2
Serpell, L.3
Narain, Y.4
Goedert, M.5
Spillantini, M.G.6
-
78
-
-
33646080573
-
Pseudophosphorylation of Tau at serine 422 inhibits caspase cleavage: In vitro evidence and implications for tangle formation in vivo
-
Guillozet-Bongaarts AL, Cahill ME, Cryns VL, Reynolds MR, Berry RW, Binder LI: Pseudophosphorylation of Tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo. J. Neurochem. 97(4), 1005-1014 (2006).
-
(2006)
J. Neurochem
, vol.97
, Issue.4
, pp. 1005-1014
-
-
Guillozet-Bongaarts, A.L.1
Cahill, M.E.2
Cryns, V.L.3
Reynolds, M.R.4
Berry, R.W.5
Binder, L.I.6
-
79
-
-
15244347753
-
Apoptotic effect of caspase-3 cleaved Tau in hippocampal neurons and its potentiation by Tau FTDP-mutation N279K
-
Fasulo L, Ugolini G, Cattaneo A: Apoptotic effect of caspase-3 cleaved Tau in hippocampal neurons and its potentiation by Tau FTDP-mutation N279K. J. Alzheimers Dis. 7(1), 3-13 (2005).
-
(2005)
J. Alzheimers Dis
, vol.7
, Issue.1
, pp. 3-13
-
-
Fasulo, L.1
Ugolini, G.2
Cattaneo, A.3
-
80
-
-
34247882772
-
Activation of caspase-6 in aging and mild cognitive impairment
-
Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC: Activation of caspase-6 in aging and mild cognitive impairment. Am. J. Pathol. 170(4), 1200-1209 (2007).
-
(2007)
Am. J. Pathol
, vol.170
, Issue.4
, pp. 1200-1209
-
-
Albrecht, S.1
Bourdeau, M.2
Bennett, D.3
Mufson, E.J.4
Bhattacharjee, M.5
LeBlanc, A.C.6
-
81
-
-
11144261132
-
Proteasome inhibition and Tau proteolysis: An unexpected regulation
-
Delobel P, Leroy O, Hamdane M, Sambo AV, Delacourte A, Buee L: Proteasome inhibition and Tau proteolysis: an unexpected regulation. FEBS Lett. 579(1), 1-5 (2005).
-
(2005)
FEBS Lett
, vol.579
, Issue.1
, pp. 1-5
-
-
Delobel, P.1
Leroy, O.2
Hamdane, M.3
Sambo, A.V.4
Delacourte, A.5
Buee, L.6
-
82
-
-
14844328111
-
The role of caspase cleavage of Tau in Alzheimer disease neuropathology
-
Cotman CW, Poon WW, Rissman RA, Blurton-Jones M: The role of caspase cleavage of Tau in Alzheimer disease neuropathology. J. Neuropathol. Exp. Neurol. 64(2), 104-112 (2005).
-
(2005)
J. Neuropathol. Exp. Neurol
, vol.64
, Issue.2
, pp. 104-112
-
-
Cotman, C.W.1
Poon, W.W.2
Rissman, R.A.3
Blurton-Jones, M.4
-
83
-
-
0038291981
-
Conformational changes and truncation of Tau protein during tangle evolution in Alzheimer's disease
-
Garcia-Sierra F, Ghoshal N, Quinn B, Berry RW, Binder LI: Conformational changes and truncation of Tau protein during tangle evolution in Alzheimer's disease. J. Alzheimers Dis. 5(2), 65-77 (2003).
-
(2003)
J. Alzheimers Dis
, vol.5
, Issue.2
, pp. 65-77
-
-
Garcia-Sierra, F.1
Ghoshal, N.2
Quinn, B.3
Berry, R.W.4
Binder, L.I.5
-
84
-
-
44649100169
-
Direct analysis of Tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved Tau containing four microtubule-binding repeats
-
Wray S, Saxton M, Anderton BH, Hanger DP: Direct analysis of Tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved Tau containing four microtubule-binding repeats. J. Neurochem. (2008)
-
(2008)
J. Neurochem
-
-
Wray, S.1
Saxton, M.2
Anderton, B.H.3
Hanger, D.P.4
-
85
-
-
0026543843
-
Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue
-
Yamada T, McGeer PL, McGeer EG: Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci. Lett. 135(1), 99-102 (1992).
-
(1992)
Neurosci. Lett
, vol.135
, Issue.1
, pp. 99-102
-
-
Yamada, T.1
McGeer, P.L.2
McGeer, E.G.3
-
86
-
-
0025609024
-
Oligodendroglial microtubular masses: An abnormality observed in some human neurodegenerative diseases
-
Yamada T, McGeer PL: Oligodendroglial microtubular masses: an abnormality observed in some human neurodegenerative diseases. Neurosci. Lett. 120(2), 163-166 (1990).
-
(1990)
Neurosci. Lett
, vol.120
, Issue.2
, pp. 163-166
-
-
Yamada, T.1
McGeer, P.L.2
-
87
-
-
0028246505
-
Corticobasal degeneration: Etiopathological significance of the cytoskeletal alterations
-
Wakabayashi K, Oyanagi K, Makifuchi T et al.: Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol. 87(6), 545-553 (1994).
-
(1994)
Acta Neuropathol
, vol.87
, Issue.6
, pp. 545-553
-
-
Wakabayashi, K.1
Oyanagi, K.2
Makifuchi, T.3
-
88
-
-
0032886469
-
Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
-
Komori T: Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol. 9(4), 663-679 (1999).
-
(1999)
Brain Pathol
, vol.9
, Issue.4
, pp. 663-679
-
-
Komori, T.1
-
89
-
-
0026700341
-
Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein
-
Hanger DP, Mann DM, Neary D, Anderton BH: Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein. Biochem. Soc. Trans. 20(3), 642-645 (1992).
-
(1992)
Biochem. Soc. Trans
, vol.20
, Issue.3
, pp. 642-645
-
-
Hanger, D.P.1
Mann, D.M.2
Neary, D.3
Anderton, B.H.4
-
90
-
-
0030748399
-
Different distribution of phosphorylated Tau protein isoforms in Alzheimer's and Pick's diseases
-
Sergeant N, David JP, Lefranc D, Vermersch P, Wattez A, Delacourte A: Different distribution of phosphorylated Tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett. 412(3), 578-582 (1997).
-
(1997)
FEBS Lett
, vol.412
, Issue.3
, pp. 578-582
-
-
Sergeant, N.1
David, J.P.2
Lefranc, D.3
Vermersch, P.4
Wattez, A.5
Delacourte, A.6
-
91
-
-
0026595846
-
Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
-
Goedert M, Spillantini MG, Cairns NJ, Crowther RA: Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8(1), 159-168 (1992).
-
(1992)
Neuron
, vol.8
, Issue.1
, pp. 159-168
-
-
Goedert, M.1
Spillantini, M.G.2
Cairns, N.J.3
Crowther, R.A.4
-
92
-
-
0033009603
-
Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively 'exon 10' isoforms
-
Sergeant N, Wattez A, Delacourte A: Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively 'exon 10' isoforms. J. Neurochem. 72(3), 1243-1249 (1999).
-
(1999)
J. Neurochem
, vol.72
, Issue.3
, pp. 1243-1249
-
-
Sergeant, N.1
Wattez, A.2
Delacourte, A.3
-
93
-
-
0036938326
-
Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of Tau protein isoforms
-
Tolnay M, Sergeant N, Ghestem A: Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of Tau protein isoforms. Acta Neuropathol. 104(4), 425-434 (2002).
-
(2002)
Acta Neuropathol
, vol.104
, Issue.4
, pp. 425-434
-
-
Tolnay, M.1
Sergeant, N.2
Ghestem, A.3
-
94
-
-
34447096691
-
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration
-
Cairns NJ, Bigio EH, Mackenzie IR et al.: Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114(1), 5-22 (2007).
-
(2007)
Acta Neuropathol
, vol.114
, Issue.1
, pp. 5-22
-
-
Cairns, N.J.1
Bigio, E.H.2
Mackenzie, I.R.3
-
95
-
-
42149118368
-
Differentiating the dementias. Revisiting synucleinopathies and tauopathies
-
Hickey C, Chisholm T, Passmore MJ, O'Brien JD, Johnston J: Differentiating the dementias. Revisiting synucleinopathies and tauopathies. Curr. Alzheimer Res. 5(1), 52-60 (2008).
-
(2008)
Curr. Alzheimer Res
, vol.5
, Issue.1
, pp. 52-60
-
-
Hickey, C.1
Chisholm, T.2
Passmore, M.J.3
O'Brien, J.D.4
Johnston, J.5
-
96
-
-
0027374233
-
Detection of Tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
-
Vandermeeren M, Mercken M, Vanmechelen E et al.: Detection of Tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61(5), 1828-1834 (1993).
-
(1993)
J. Neurochem
, vol.61
, Issue.5
, pp. 1828-1834
-
-
Vandermeeren, M.1
Mercken, M.2
Vanmechelen, E.3
-
97
-
-
0037315940
-
Differentiation of geriatric major depression from Alzheimer's disease with CSF Tau protein phosphorylated at threonine 231
-
Buerger K, Zinkowski R, Teipel SJ et al.: Differentiation of geriatric major depression from Alzheimer's disease with CSF Tau protein phosphorylated at threonine 231. Am. J. Psychiatry 160(2), 376-379 (2003).
-
(2003)
Am. J. Psychiatry
, vol.160
, Issue.2
, pp. 376-379
-
-
Buerger, K.1
Zinkowski, R.2
Teipel, S.J.3
-
98
-
-
7444253126
-
Cerebrospinal fluid protein biomarkers for Alzheimer's disease
-
Blennow K: Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 1(2), 213-225 (2004).
-
(2004)
NeuroRx
, vol.1
, Issue.2
, pp. 213-225
-
-
Blennow, K.1
-
99
-
-
0042591226
-
CSF markers for pathogenic processes in Alzheimer's disease: Diagnostic implications and use in clinical neurochemistry
-
Blennow K, Vanmechelen E: CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry. Brain Res. Bull. 61(3), 235-242 (2003).
-
(2003)
Brain Res. Bull
, vol.61
, Issue.3
, pp. 235-242
-
-
Blennow, K.1
Vanmechelen, E.2
-
100
-
-
0034741554
-
Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values
-
Sjogren M, Vanderstichele H, Agren H et al.: Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin. Chem. 47(10), 1776-1781 (2001).
-
(2001)
Clin. Chem
, vol.47
, Issue.10
, pp. 1776-1781
-
-
Sjogren, M.1
Vanderstichele, H.2
Agren, H.3
-
101
-
-
0346124139
-
Cerebrospinal fluid Tau and β-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
-
Clark CM, Xie S, Chittams J et al.: Cerebrospinal fluid Tau and β-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch. Neurol. 60(12), 1696-1702 (2003).
-
(2003)
Arch. Neurol
, vol.60
, Issue.12
, pp. 1696-1702
-
-
Clark, C.M.1
Xie, S.2
Chittams, J.3
-
102
-
-
0031583947
-
The level of cerebrospinal fluid Tau correlates with neurofibrillary tangles in Alzheimer's disease
-
Tapiola T, Overmyer M, Lehtovirta M et al.: The level of cerebrospinal fluid Tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport 8(18), 3961-3963 (1997).
-
(1997)
Neuroreport
, vol.8
, Issue.18
, pp. 3961-3963
-
-
Tapiola, T.1
Overmyer, M.2
Lehtovirta, M.3
-
103
-
-
33747689817
-
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
-
Sanchez-Juan P, Green A, Ladogana A et al.: CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67(4), 637-643 (2006).
-
(2006)
Neurology
, vol.67
, Issue.4
, pp. 637-643
-
-
Sanchez-Juan, P.1
Green, A.2
Ladogana, A.3
-
104
-
-
29644440387
-
Raised CSF phospho-Tau concentrations in variant Creutzfeldt-Jakob disease: Diagnostic and pathological implications
-
Goodall CA, Head MW, Everington D, Ironside JW, Knight RS, Green AJ: Raised CSF phospho-Tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications. J. Neurol. Neurosurg. Psychiatr. 77(1), 89-91 (2006).
-
(2006)
J. Neurol. Neurosurg. Psychiatr
, vol.77
, Issue.1
, pp. 89-91
-
-
Goodall, C.A.1
Head, M.W.2
Everington, D.3
Ironside, J.W.4
Knight, R.S.5
Green, A.J.6
-
105
-
-
20444494388
-
Cerebrospinal fluid levels of markers of brain parenchymal damage in Vietnamese adults with severe malaria
-
Medana IM, Lindert RB, Wurster U et al.: Cerebrospinal fluid levels of markers of brain parenchymal damage in Vietnamese adults with severe malaria. Trans. R. Soc. Trop. Med. Hyg. 99(8), 610-617 (2005).
-
(2005)
Trans. R. Soc. Trop. Med. Hyg
, vol.99
, Issue.8
, pp. 610-617
-
-
Medana, I.M.1
Lindert, R.B.2
Wurster, U.3
-
106
-
-
44349095753
-
Elevated cerebrospinal fluid Tau protein levels in Wernicke's encephalopathy
-
Matsushita S, Miyakawa T, Maesato H et al.: Elevated cerebrospinal fluid Tau protein levels in Wernicke's encephalopathy. Alcohol. Clin. Exp. Res. 32(6), 1091-1095 (2008).
-
(2008)
Alcohol. Clin. Exp. Res
, vol.32
, Issue.6
, pp. 1091-1095
-
-
Matsushita, S.1
Miyakawa, T.2
Maesato, H.3
-
107
-
-
43549110084
-
Increased total Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients
-
de Bont JM, Vanderstichele H, Reddingius RE, Pieters R, van Gool SW: Increased total Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients. Eur. J. Paediatr. Neurol. 12(4), 334-341 (2008).
-
(2008)
Eur. J. Paediatr. Neurol
, vol.12
, Issue.4
, pp. 334-341
-
-
de Bont, J.M.1
Vanderstichele, H.2
Reddingius, R.E.3
Pieters, R.4
van Gool, S.W.5
-
108
-
-
43249106998
-
CSF biomarkers in frontotemporal lobar degeneration with known pathology
-
Bian H, Van Swieten JC, Leight S et al.: CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70(19 Pt 2), 1827-1835 (2008).
-
(2008)
Neurology
, vol.70
, Issue.19 PART 2
, pp. 1827-1835
-
-
Bian, H.1
Van Swieten, J.C.2
Leight, S.3
-
109
-
-
20944439059
-
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease
-
Grossman M, Farmer J, Leight S et al.: Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann. Neurol. 57(5), 721-729 (2005).
-
(2005)
Ann. Neurol
, vol.57
, Issue.5
, pp. 721-729
-
-
Grossman, M.1
Farmer, J.2
Leight, S.3
-
110
-
-
4344580599
-
CSF Tau and Aβ42 are not useful in the diagnosis of frontotemporal lobar degeneration
-
Pijnenburg YA, Schoonenboom NS, Rosso SM et al.: CSF Tau and Aβ42 are not useful in the diagnosis of frontotemporal lobar degeneration. Neurology 62(9), 1649 (2004).
-
(2004)
Neurology
, vol.62
, Issue.9
, pp. 1649
-
-
Pijnenburg, Y.A.1
Schoonenboom, N.S.2
Rosso, S.M.3
-
111
-
-
47049100511
-
Cerebrospinal fluid biomarkers in parkinson's disease with dementia and dementia with lewy Bodies
-
Parnetti L, Tiraboschi P, Lanari A et al.: Cerebrospinal fluid biomarkers in parkinson's disease with dementia and dementia with lewy Bodies. Biol. Psychiatry (2008)
-
(2008)
Biol. Psychiatry
-
-
Parnetti, L.1
Tiraboschi, P.2
Lanari, A.3
-
112
-
-
20644469257
-
Tau protein, Aβ42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies
-
Mollenhauer B, Cepek L, Bibl M et al.: Tau protein, Aβ42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies. Dement. Geriatr. Cogn. Disord. 19(2-3), 164-170 (2005).
-
(2005)
Dement. Geriatr. Cogn. Disord
, vol.19
, Issue.2-3
, pp. 164-170
-
-
Mollenhauer, B.1
Cepek, L.2
Bibl, M.3
-
113
-
-
33750455449
-
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
-
Bibl M, Mollenhauer B, Esselmann H et al.: CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies. J. Neural Transm. 113(11), 1771-1778 (2006).
-
(2006)
J. Neural Transm
, vol.113
, Issue.11
, pp. 1771-1778
-
-
Bibl, M.1
Mollenhauer, B.2
Esselmann, H.3
-
114
-
-
0035957114
-
Decreased CSF amyloid β42 and normal Tau levels in dementia with Lewy bodies
-
Tschampa HJ, Schulz-Schaeffer W, Wiltfang J et al.: Decreased CSF amyloid β42 and normal Tau levels in dementia with Lewy bodies. Neurology 56(4), 576 (2001).
-
(2001)
Neurology
, vol.56
, Issue.4
, pp. 576
-
-
Tschampa, H.J.1
Schulz-Schaeffer, W.2
Wiltfang, J.3
-
115
-
-
33748163112
-
β-amlyoid 1-42 and Tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia
-
Mollenhauer B, Trenkwalder C, von Ahsen N et al.: β-amlyoid 1-42 and Tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dement. Geriatr. Cogn. Disord. 22(3), 200-208 (2006).
-
(2006)
Dement. Geriatr. Cogn. Disord
, vol.22
, Issue.3
, pp. 200-208
-
-
Mollenhauer, B.1
Trenkwalder, C.2
von Ahsen, N.3
-
116
-
-
44649192788
-
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
-
Borroni B, Gardoni F, Parnetti L et al.: Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol. Aging (2007)
-
(2007)
Neurobiol. Aging
-
-
Borroni, B.1
Gardoni, F.2
Parnetti, L.3
-
117
-
-
33645800776
-
Axonal damage markers in cerebrospinal fluid are increased in ALS
-
Brettschneider J, Petzold A, Sussmuth SD, Ludolph AC, Tumani H: Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66(6), 852-856 (2006).
-
(2006)
Neurology
, vol.66
, Issue.6
, pp. 852-856
-
-
Brettschneider, J.1
Petzold, A.2
Sussmuth, S.D.3
Ludolph, A.C.4
Tumani, H.5
-
118
-
-
19944434221
-
Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
-
Jimenez-Jimenez FJ, Hernanz A, Medina-Acebron S et al.: Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 111(2), 114-117 (2005).
-
(2005)
Acta Neurol. Scand
, vol.111
, Issue.2
, pp. 114-117
-
-
Jimenez-Jimenez, F.J.1
Hernanz, A.2
Medina-Acebron, S.3
-
119
-
-
39449123012
-
Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia
-
Boban M, Grbic K, Mladinov M et al.: Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia. Coll. Antropol. 32(Suppl. 1), 31-36 (2008).
-
(2008)
Coll. Antropol
, vol.32
, Issue.SUPPL. 1
, pp. 31-36
-
-
Boban, M.1
Grbic, K.2
Mladinov, M.3
-
120
-
-
41949128622
-
Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis
-
Hein Née Maier K, Kohler A, Diem R et al.: Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis. Neurosci. Lett. 436(1), 72-76 (2008).
-
(2008)
Neurosci. Lett
, vol.436
, Issue.1
, pp. 72-76
-
-
Hein1
Née Maier, K.2
Kohler, A.3
Diem, R.4
-
121
-
-
20144377153
-
Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis
-
Brettschneider J, Maier M, Arda S et al.: Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis. Mult. Scler. 11(3), 261-265 (2005).
-
(2005)
Mult. Scler
, vol.11
, Issue.3
, pp. 261-265
-
-
Brettschneider, J.1
Maier, M.2
Arda, S.3
-
122
-
-
25144513449
-
CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment
-
Blennow K: CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment. Expert Rev. Mol. Diagn. 5(5), 661-672 (2005).
-
(2005)
Expert Rev. Mol. Diagn
, vol.5
, Issue.5
, pp. 661-672
-
-
Blennow, K.1
-
123
-
-
9144257234
-
Measurement of phosphorylated Tau epitopes in the differential diagnosis of Alzheimer disease: A comparative cerebrospinal fluid study
-
Hampel H, Buerger K, Zinkowski R et al.: Measurement of phosphorylated Tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch. Gen. Psychiatry 61(1), 95-102 (2004).
-
(2004)
Arch. Gen. Psychiatry
, vol.61
, Issue.1
, pp. 95-102
-
-
Hampel, H.1
Buerger, K.2
Zinkowski, R.3
-
124
-
-
0037837209
-
Phospho-Tau/total Tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
-
Riemenschneider M, Wagenpfeil S, Vanderstichele H et al.: Phospho-Tau/total Tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol. Psychiatry 8(3), 343-347 (2003).
-
(2003)
Mol. Psychiatry
, vol.8
, Issue.3
, pp. 343-347
-
-
Riemenschneider, M.1
Wagenpfeil, S.2
Vanderstichele, H.3
-
125
-
-
0036182732
-
Decreased CSF-β-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of β-amyloid induced by disparate mechanisms
-
Sjogren M, Davidsson P, Wallin A et al.: Decreased CSF-β-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of β-amyloid induced by disparate mechanisms. Dement. Geriatr. Cogn. Disord. 13(2), 112-118 (2002).
-
(2002)
Dement. Geriatr. Cogn. Disord
, vol.13
, Issue.2
, pp. 112-118
-
-
Sjogren, M.1
Davidsson, P.2
Wallin, A.3
-
126
-
-
0036338203
-
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of Tau protein phosphorylated at threonine 231
-
Buerger K, Zinkowski R, Teipel SJ et al.: Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of Tau protein phosphorylated at threonine 231. Arch. Neurol. 59(8), 1267-1272 (2002).
-
(2002)
Arch. Neurol
, vol.59
, Issue.8
, pp. 1267-1272
-
-
Buerger, K.1
Zinkowski, R.2
Teipel, S.J.3
-
127
-
-
33845713197
-
Analytical performance and clinical utility of the INNOTEST PHOSPHOTAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
-
Vanderstichele H, De Vreese K, Blennow K et al.: Analytical performance and clinical utility of the INNOTEST PHOSPHOTAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clin. Chem. Lab. Med. 44(12), 1472-1480 (2006).
-
(2006)
Clin. Chem. Lab. Med
, vol.44
, Issue.12
, pp. 1472-1480
-
-
Vanderstichele, H.1
De Vreese, K.2
Blennow, K.3
-
128
-
-
25444467706
-
Cerebrospinal fluid Tau levels in frontotemporal dementia
-
Verbeek MM, Pijnenburg YA, Schoonenboom NS, Kremer BP, Scheltens P: Cerebrospinal fluid Tau levels in frontotemporal dementia. Ann. Neurol. 58(4), 656-657 (2005).
-
(2005)
Ann. Neurol
, vol.58
, Issue.4
, pp. 656-657
-
-
Verbeek, M.M.1
Pijnenburg, Y.A.2
Schoonenboom, N.S.3
Kremer, B.P.4
Scheltens, P.5
-
129
-
-
10744229989
-
Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total Tau
-
Lewczuk P, Esselmann H, Otto M et al.: Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total Tau. Neurobiol. Aging 25(3), 273-281 (2004).
-
(2004)
Neurobiol. Aging
, vol.25
, Issue.3
, pp. 273-281
-
-
Lewczuk, P.1
Esselmann, H.2
Otto, M.3
-
130
-
-
33745225239
-
Stability of CSF β-amyloid(1-42) and Tau levels by APOE genotype in Alzheimer patients
-
Huey ED, Mirza N, Putnam KT et al.: Stability of CSF β-amyloid(1-42) and Tau levels by APOE genotype in Alzheimer patients. Dement. Geriatr. Cogn. Disord. 22(1), 48-53 (2006).
-
(2006)
Dement. Geriatr. Cogn. Disord
, vol.22
, Issue.1
, pp. 48-53
-
-
Huey, E.D.1
Mirza, N.2
Putnam, K.T.3
-
131
-
-
33644532549
-
Towards compendia of negative genetic association studies: An example for Alzheimer disease
-
Blomqvist ME, Reynolds C, Katzov H et al.: Towards compendia of negative genetic association studies: an example for Alzheimer disease. Hum. Genet. 119(1-2), 29-37 (2006).
-
(2006)
Hum. Genet
, vol.119
, Issue.1-2
, pp. 29-37
-
-
Blomqvist, M.E.1
Reynolds, C.2
Katzov, H.3
-
132
-
-
23844537812
-
TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease
-
Johansson A, Zetterberg H, Hakansson A, Nissbrandt H, Blennow K: TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease. Neurodegener. Dis. 2(1), 28-35 (2005).
-
(2005)
Neurodegener. Dis
, vol.2
, Issue.1
, pp. 28-35
-
-
Johansson, A.1
Zetterberg, H.2
Hakansson, A.3
Nissbrandt, H.4
Blennow, K.5
-
133
-
-
45849122478
-
Variation in MAPT is associated with cerebrospinal fluid Tau levels in the presence of amyloid-β deposition
-
Kauwe JS, Cruchaga C, Mayo K et al.: Variation in MAPT is associated with cerebrospinal fluid Tau levels in the presence of amyloid-β deposition. Proc. Natl Acad. Sci. USA 105(23), 8050-8054 (2008).
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, Issue.23
, pp. 8050-8054
-
-
Kauwe, J.S.1
Cruchaga, C.2
Mayo, K.3
-
134
-
-
0031951155
-
CSF Tau is related to apolipoprotein E genotype in early Alzheimer's disease
-
Tapiola T, Lehtovirta M, Ramberg J et al.: CSF Tau is related to apolipoprotein E genotype in early Alzheimer's disease. Neurology 50(1), 169-174 (1998).
-
(1998)
Neurology
, vol.50
, Issue.1
, pp. 169-174
-
-
Tapiola, T.1
Lehtovirta, M.2
Ramberg, J.3
-
135
-
-
0033607601
-
Tau and apo E in CSF: Potential aid for discriminating Alzheimer's disease from other dementias
-
Molina L, Touchon J, Herpe M et al.: Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias. Neuroreport 10(17), 3491-3495 (1999).
-
(1999)
Neuroreport
, vol.10
, Issue.17
, pp. 3491-3495
-
-
Molina, L.1
Touchon, J.2
Herpe, M.3
-
136
-
-
0343471538
-
Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease
-
Golombowski S, Muller-Spahn F, Romig H, Mendla K, Hock C: Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease. Neurosci. Lett. 225(3), 213-215 (1997).
-
(1997)
Neurosci. Lett
, vol.225
, Issue.3
, pp. 213-215
-
-
Golombowski, S.1
Muller-Spahn, F.2
Romig, H.3
Mendla, K.4
Hock, C.5
-
137
-
-
0031971616
-
The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease
-
Galasko D: The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease. West. J. Med. 168(4), 264-265 (1998).
-
(1998)
West. J. Med
, vol.168
, Issue.4
, pp. 264-265
-
-
Galasko, D.1
-
138
-
-
34247496428
-
Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease
-
Laws SM, Friedrich P, Diehl-Schmid J et al.: Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease. Mol. Psychiatry 12(5), 510-517 (2007).
-
(2007)
Mol. Psychiatry
, vol.12
, Issue.5
, pp. 510-517
-
-
Laws, S.M.1
Friedrich, P.2
Diehl-Schmid, J.3
-
139
-
-
4544250975
-
Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease
-
Dhaenens CM, Van Brussel E, Schraen-Maschke S, Pasquier F, Delacourte A, Sablonniere B: Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neurosci. Lett. 368(3), 290-292 (2004).
-
(2004)
Neurosci. Lett
, vol.368
, Issue.3
, pp. 290-292
-
-
Dhaenens, C.M.1
Van Brussel, E.2
Schraen-Maschke, S.3
Pasquier, F.4
Delacourte, A.5
Sablonniere, B.6
-
140
-
-
34347242354
-
Kinesin gene variability may affect Tau phosphorylation in early Alzheimer's disease
-
Andersson ME, Sjolander A, Andreasen N et al.: Kinesin gene variability may affect Tau phosphorylation in early Alzheimer's disease. Int. J. Mol. Med. 20(2), 233-239 (2007).
-
(2007)
Int. J. Mol. Med
, vol.20
, Issue.2
, pp. 233-239
-
-
Andersson, M.E.1
Sjolander, A.2
Andreasen, N.3
-
141
-
-
34447322271
-
Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria
-
Dubois B, Feldman HH, Jacova C et al.: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6(8), 734-746 (2007).
-
(2007)
Lancet Neurol
, vol.6
, Issue.8
, pp. 734-746
-
-
Dubois, B.1
Feldman, H.H.2
Jacova, C.3
-
142
-
-
17044430985
-
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
-
Andreasen N, Blennow K: CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin. Neurol. Neurosurg. 107(3), 165-173 (2005).
-
(2005)
Clin. Neurol. Neurosurg
, vol.107
, Issue.3
, pp. 165-173
-
-
Andreasen, N.1
Blennow, K.2
-
143
-
-
0037244487
-
Cerebrospinal fluid levels of total-Tau, phospho-Tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment
-
Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K: Cerebrospinal fluid levels of total-Tau, phospho-Tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. Acta Neurol. Scand. Suppl. 179, 47-51 (2003).
-
(2003)
Acta Neurol. Scand. Suppl
, vol.179
, pp. 47-51
-
-
Andreasen, N.1
Vanmechelen, E.2
Vanderstichele, H.3
Davidsson, P.4
Blennow, K.5
-
144
-
-
37349026227
-
Multicenter assessment of CSF-phosphorylated Tau for the prediction of conversion of MCI
-
Ewers M, Buerger K, Teipel SJ et al.: Multicenter assessment of CSF-phosphorylated Tau for the prediction of conversion of MCI. Neurology 69(24), 2205-2212 (2007).
-
(2007)
Neurology
, vol.69
, Issue.24
, pp. 2205-2212
-
-
Ewers, M.1
Buerger, K.2
Teipel, S.J.3
-
145
-
-
0037183481
-
CSF Tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
-
Buerger K, Teipel SJ, Zinkowski R et al.: CSF Tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology 59(4), 627-629 (2002).
-
(2002)
Neurology
, vol.59
, Issue.4
, pp. 627-629
-
-
Buerger, K.1
Teipel, S.J.2
Zinkowski, R.3
-
146
-
-
31844440459
-
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
-
de Leon MJ, DeSanti S, Zinkowski R et al.: Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol. Aging 27(3), 394-401 (2006).
-
(2006)
Neurobiol. Aging
, vol.27
, Issue.3
, pp. 394-401
-
-
de Leon, M.J.1
DeSanti, S.2
Zinkowski, R.3
-
147
-
-
32544435900
-
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study
-
Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 5(3), 228-234 (2006).
-
(2006)
Lancet Neurol
, vol.5
, Issue.3
, pp. 228-234
-
-
Hansson, O.1
Zetterberg, H.2
Buchhave, P.3
Londos, E.4
Blennow, K.5
Minthon, L.6
-
148
-
-
16844382811
-
CSF Aβ42 and Tau or phosphorylated Tau and prediction of progressive mild cognitive impairment
-
Herukka SK, Hallikainen M, Soininen H, Pirttila T: CSF Aβ42 and Tau or phosphorylated Tau and prediction of progressive mild cognitive impairment. Neurology 64(7), 1294-1297 (2005).
-
(2005)
Neurology
, vol.64
, Issue.7
, pp. 1294-1297
-
-
Herukka, S.K.1
Hallikainen, M.2
Soininen, H.3
Pirttila, T.4
-
149
-
-
33847204043
-
CSF Aβ42, Tau and phosphorylated Tau, APOE ε4 allele and MCI type in progressive MCI
-
Herukka SK, Helisalmi S, Hallikainen M, Tervo S, Soininen H, Pirttila T: CSF Aβ42, Tau and phosphorylated Tau, APOE ε4 allele and MCI type in progressive MCI. Neurobiol. Aging 28(4), 507-514 (2007).
-
(2007)
Neurobiol. Aging
, vol.28
, Issue.4
, pp. 507-514
-
-
Herukka, S.K.1
Helisalmi, S.2
Hallikainen, M.3
Tervo, S.4
Soininen, H.5
Pirttila, T.6
-
150
-
-
38049036228
-
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
-
Brys M, Pirraglia E, Rich K et al.: Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol. Aging (2007)
-
(2007)
Neurobiol. Aging
-
-
Brys, M.1
Pirraglia, E.2
Rich, K.3
-
151
-
-
0042512345
-
Mild cognitive impairment: Prevalence, prognosis, aetiology, and treatment
-
DeCarli C: Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2(1), 15-21 (2003).
-
(2003)
Lancet Neurol
, vol.2
, Issue.1
, pp. 15-21
-
-
DeCarli, C.1
-
152
-
-
47549117283
-
Biochemical markers in persons with preclinical familial Alzheimer disease
-
Ringman JM, Younkin SG, Pratico D et al.: Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology 71(2), 85-92 (2008).
-
(2008)
Neurology
, vol.71
, Issue.2
, pp. 85-92
-
-
Ringman, J.M.1
Younkin, S.G.2
Pratico, D.3
-
153
-
-
2442586536
-
Tau protein in cerebrospinal fluid: A possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
-
Martinez-Yelamos A, Saiz A, Bas J, Hernandez JJ, Graus F, Arbizu T: Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis. Neurosci. Lett. 363(1), 14-17 (2004).
-
(2004)
Neurosci. Lett
, vol.363
, Issue.1
, pp. 14-17
-
-
Martinez-Yelamos, A.1
Saiz, A.2
Bas, J.3
Hernandez, J.J.4
Graus, F.5
Arbizu, T.6
-
154
-
-
33750376704
-
CSF Tau protein: A new prognostic marker for Guillain-Barre syndrome
-
Jin K, Takeda A, Shiga Y et al.: CSF Tau protein: a new prognostic marker for Guillain-Barre syndrome. Neurology 67(8), 1470-1472 (2006).
-
(2006)
Neurology
, vol.67
, Issue.8
, pp. 1470-1472
-
-
Jin, K.1
Takeda, A.2
Shiga, Y.3
-
155
-
-
33750999347
-
Initial CSF total Tau correlates with 1-year outcome in patients with traumatic brain injury
-
Ost M, Nylen K, Csajbok L et al.: Initial CSF total Tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 67(9), 1600-1604 (2006).
-
(2006)
Neurology
, vol.67
, Issue.9
, pp. 1600-1604
-
-
Ost, M.1
Nylen, K.2
Csajbok, L.3
-
156
-
-
36549078600
-
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years
-
Zetterberg H, Pedersen M, Lind K et al.: Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years. J. Alzheimers Dis. 12(3), 255-260 (2007).
-
(2007)
J. Alzheimers Dis
, vol.12
, Issue.3
, pp. 255-260
-
-
Zetterberg, H.1
Pedersen, M.2
Lind, K.3
-
157
-
-
0141738373
-
CSF markers for incipient Alzheimer's disease
-
Blennow K, Hampel H: CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2(10), 605-613 (2003).
-
(2003)
Lancet Neurol
, vol.2
, Issue.10
, pp. 605-613
-
-
Blennow, K.1
Hampel, H.2
-
158
-
-
1542313783
-
Core biological marker candidates of Alzheimer's disease: Perspectives for diagnosis, prediction of outcome and reflection of biological activity
-
Hampel H, Mitchell A, Blennow K et al.: Core biological marker candidates of Alzheimer's disease: perspectives for diagnosis, prediction of outcome and reflection of biological activity. J. Neural Transm. 111(3), 247-272 (2004).
-
(2004)
J. Neural Transm
, vol.111
, Issue.3
, pp. 247-272
-
-
Hampel, H.1
Mitchell, A.2
Blennow, K.3
-
159
-
-
21244457198
-
Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia
-
Wiltfang J, Lewczuk P, Riederer P et al.: Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J. Biol. Psychiatryy 6(2), 69-84 (2005).
-
(2005)
World J. Biol. Psychiatryy
, vol.6
, Issue.2
, pp. 69-84
-
-
Wiltfang, J.1
Lewczuk, P.2
Riederer, P.3
-
160
-
-
44949219321
-
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
-
Engelborghs S, De Vreese K, Van de Casteele T et al.: Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol. Aging 29(8), 1143-1159 (2008).
-
(2008)
Neurobiol. Aging
, vol.29
, Issue.8
, pp. 1143-1159
-
-
Engelborghs, S.1
De Vreese, K.2
Van de Casteele, T.3
-
161
-
-
34548450659
-
Longitudinal changes of CSF biomarkers in memory clinic patients
-
Bouwman FH, van der Flier WM, Schoonenboom NS et al.: Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 69(10), 1006-1011 (2007).
-
(2007)
Neurology
, vol.69
, Issue.10
, pp. 1006-1011
-
-
Bouwman, F.H.1
van der Flier, W.M.2
Schoonenboom, N.S.3
-
162
-
-
54849419105
-
The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease
-
Bahl JM, Heegaard NH, Falkenhorst G et al.: The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Neurobiol. Aging (2008)
-
(2008)
Neurobiol. Aging
-
-
Bahl, J.M.1
Heegaard, N.H.2
Falkenhorst, G.3
-
163
-
-
22144434340
-
Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease
-
Van Everbroeck B, Boons J, Cras P: Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin. Neurol. Neurosurg. 107(5), 355-360 (2005).
-
(2005)
Clin. Neurol. Neurosurg
, vol.107
, Issue.5
, pp. 355-360
-
-
Van Everbroeck, B.1
Boons, J.2
Cras, P.3
-
164
-
-
0035100888
-
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
-
Atkinson AJ: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89-95 (2001).
-
(2001)
Clin. Pharmacol. Ther
, vol.69
, pp. 89-95
-
-
Atkinson, A.J.1
-
165
-
-
33947223454
-
Cerebrospinal fluid Tau/β-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults
-
Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM: Cerebrospinal fluid Tau/β-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 64(3), 343-349 (2007).
-
(2007)
Arch. Neurol
, vol.64
, Issue.3
, pp. 343-349
-
-
Fagan, A.M.1
Roe, C.M.2
Xiong, C.3
Mintun, M.A.4
Morris, J.C.5
Holtzman, D.M.6
-
166
-
-
32044436030
-
CSF biomarkers for Alzheimer's disease: Levels of β-amyloid, Tau, phosphorylated Tau relate to clinical symptoms and survival
-
Wallin AK, Blennow K, Andreasen N, Minthon L: CSF biomarkers for Alzheimer's disease: levels of β-amyloid, Tau, phosphorylated Tau relate to clinical symptoms and survival. Dement. Geriatr. Cogn. Disord. 21(3), 131-138 (2006).
-
(2006)
Dement. Geriatr. Cogn. Disord
, vol.21
, Issue.3
, pp. 131-138
-
-
Wallin, A.K.1
Blennow, K.2
Andreasen, N.3
Minthon, L.4
-
167
-
-
49649124175
-
Increasing CSF phospho-Tau levels during cognitive decline and progression to dementia
-
Andersson C, Blennow K, Almkvist O et al.: Increasing CSF phospho-Tau levels during cognitive decline and progression to dementia. Neurobiol. Aging (2007)
-
(2007)
Neurobiol. Aging
-
-
Andersson, C.1
Blennow, K.2
Almkvist, O.3
-
168
-
-
0037457354
-
Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients
-
Wahlund LO, Blennow K: Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neurosci. Lett. 339(2), 99-102 (2003).
-
(2003)
Neurosci. Lett
, vol.339
, Issue.2
, pp. 99-102
-
-
Wahlund, L.O.1
Blennow, K.2
-
169
-
-
47849108205
-
CSF Aβ42 Tau and phosphorylated Tau correlate with medial temporal lobe atrophy
-
Herukka SK, Pennanen C, Soininen H, Pirttila T: CSF Aβ42 Tau and phosphorylated Tau correlate with medial temporal lobe atrophy. J. Alzheimers Dis. 14(1), 51-57 (2008).
-
(2008)
J. Alzheimers Dis
, vol.14
, Issue.1
, pp. 51-57
-
-
Herukka, S.K.1
Pennanen, C.2
Soininen, H.3
Pirttila, T.4
-
170
-
-
54849414660
-
Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years
-
Stomrud E, Hansson O, Minthon L, Blennow K, Rosen I, Londos E: Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years. Neurobiol. Aging (2008)
-
(2008)
Neurobiol. Aging
-
-
Stomrud, E.1
Hansson, O.2
Minthon, L.3
Blennow, K.4
Rosen, I.5
Londos, E.6
-
171
-
-
20444388706
-
Microtubule-associated protein Tau: A marker of paclitaxel sensitivity in breast cancer
-
Rouzier R, Rajan R, Wagner P et al.: Microtubule-associated protein Tau: a marker of paclitaxel sensitivity in breast cancer. Proc. Natl Acad. Sci. USA 102(23), 8315-8320 (2005).
-
(2005)
Proc. Natl Acad. Sci. USA
, vol.102
, Issue.23
, pp. 8315-8320
-
-
Rouzier, R.1
Rajan, R.2
Wagner, P.3
-
172
-
-
2442642836
-
Retarded axonal transport of R406W mutant Tau in transgenic mice with a neurodegenerative tauopathy
-
Zhang B, Higuchi M, Yoshiyama Y et al.: Retarded axonal transport of R406W mutant Tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 24(19), 4657-4667 (2004).
-
(2004)
J. Neurosci
, vol.24
, Issue.19
, pp. 4657-4667
-
-
Zhang, B.1
Higuchi, M.2
Yoshiyama, Y.3
-
173
-
-
0141867804
-
Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: Cleaved microtubule-associated protein-Tau (C-Tau)
-
Zemlan FP, Mulchahey JJ, Gudelsky GA: Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: cleaved microtubule-associated protein-Tau (C-Tau). Neuroscience 121(2), 399-409 (2003).
-
(2003)
Neuroscience
, vol.121
, Issue.2
, pp. 399-409
-
-
Zemlan, F.P.1
Mulchahey, J.J.2
Gudelsky, G.A.3
-
174
-
-
52049096219
-
Characterization of Tau in cerebrospinal fluid using mass spectrometry
-
Portelius E, Hansson SF, Tran AJ et al.: Characterization of Tau in cerebrospinal fluid using mass spectrometry. J. Proteome Res. 7(5), 2114-2120 (2008).
-
(2008)
J. Proteome Res
, vol.7
, Issue.5
, pp. 2114-2120
-
-
Portelius, E.1
Hansson, S.F.2
Tran, A.J.3
-
175
-
-
37449000878
-
Detection of Alzheimer's Tau protein using localised surface plasmon resonance-based immunochip
-
Vestergaard M, Kerman K, Kim DK, Ha MH, Tamiya E: Detection of Alzheimer's Tau protein using localised surface plasmon resonance-based immunochip. Talanta 74(4), 1038-1042 (2008).
-
(2008)
Talanta
, vol.74
, Issue.4
, pp. 1038-1042
-
-
Vestergaard, M.1
Kerman, K.2
Kim, D.K.3
Ha, M.H.4
Tamiya, E.5
-
176
-
-
33644864034
-
Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study
-
States DJ, Omenn GS, Blackwell TW et al.: Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 24(3), 333-338 (2006).
-
(2006)
Nat. Biotechnol
, vol.24
, Issue.3
, pp. 333-338
-
-
States, D.J.1
Omenn, G.S.2
Blackwell, T.W.3
-
177
-
-
19044376179
-
Serum Tau protein level as a marker of axonal damage in acute ischemic stroke
-
Bitsch A, Horn C, Kemmling Y et al.: Serum Tau protein level as a marker of axonal damage in acute ischemic stroke. Eur. Neurol. 47(1), 45-51 (2002).
-
(2002)
Eur. Neurol
, vol.47
, Issue.1
, pp. 45-51
-
-
Bitsch, A.1
Horn, C.2
Kemmling, Y.3
-
178
-
-
33746929545
-
Neuron-specific enolase and Tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke
-
Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M: Neuron-specific enolase and Tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin. Neurol. Neurosurg. 108(6), 558-563 (2006).
-
(2006)
Clin. Neurol. Neurosurg
, vol.108
, Issue.6
, pp. 558-563
-
-
Wunderlich, M.T.1
Lins, H.2
Skalej, M.3
Wallesch, C.W.4
Goertler, M.5
-
179
-
-
0037154135
-
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
-
Otto M, Wiltfang J, Cepek L et al.: Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58(2), 192-197 (2002).
-
(2002)
Neurology
, vol.58
, Issue.2
, pp. 192-197
-
-
Otto, M.1
Wiltfang, J.2
Cepek, L.3
-
180
-
-
0036126040
-
Serum cleaved Tau protein levels and clinical outcome in adult patients with closed head injury
-
Shaw GJ, Jauch EC, Zemlan FP: Serum cleaved Tau protein levels and clinical outcome in adult patients with closed head injury. Ann. Emerg. Med. 39(3), 254-257 (2002).
-
(2002)
Ann. Emerg. Med
, vol.39
, Issue.3
, pp. 254-257
-
-
Shaw, G.J.1
Jauch, E.C.2
Zemlan, F.P.3
-
181
-
-
0037162967
-
C-Tau biomarker of neuronal damage in severe brain injured patients: Association with elevated intracranial pressure and clinical outcome
-
Zemlan FP, Jauch EC, Mulchahey JJ et al.: C-Tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947(1), 131-139 (2002).
-
(2002)
Brain Res
, vol.947
, Issue.1
, pp. 131-139
-
-
Zemlan, F.P.1
Jauch, E.C.2
Mulchahey, J.J.3
-
182
-
-
18744406008
-
Discordant temporal patterns of S100β and cleaved Tau protein elevation after head injury: A pilot study
-
Chatfield DA, Zemlan FP, Day DJ, Menon DK: Discordant temporal patterns of S100β and cleaved Tau protein elevation after head injury: a pilot study. Br. J. Neurosurg. 16(5), 471-476 (2002).
-
(2002)
Br. J. Neurosurg
, vol.16
, Issue.5
, pp. 471-476
-
-
Chatfield, D.A.1
Zemlan, F.P.2
Day, D.J.3
Menon, D.K.4
-
183
-
-
0036107977
-
Levels of nonphosphorylated and phosphorylated Tau in cerebrospinal fluid of Alzheimer's disease patients: An ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay
-
Hu YY, He SS, Wang X et al.: Levels of nonphosphorylated and phosphorylated Tau in cerebrospinal fluid of Alzheimer's disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am. J. Pathol. 160(4), 1269-1278 (2002).
-
(2002)
Am. J. Pathol
, vol.160
, Issue.4
, pp. 1269-1278
-
-
Hu, Y.Y.1
He, S.S.2
Wang, X.3
-
184
-
-
14444269228
-
Longitudinal study of cerebrospinal fluid levels of Tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: A study in Japan
-
Kanai M, Matsubara E, Isoe K et al.: Longitudinal study of cerebrospinal fluid levels of Tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: a study in Japan. Ann. Neurol. 44(1), 17-26 (1998).
-
(1998)
Ann. Neurol
, vol.44
, Issue.1
, pp. 17-26
-
-
Kanai, M.1
Matsubara, E.2
Isoe, K.3
-
185
-
-
0032693829
-
Sensitivity, specificity, and stability of CSF-Tau in AD in a community-based patient sample
-
Andreasen N, Minthon L, Clarberg A et al.: Sensitivity, specificity, and stability of CSF-Tau in AD in a community-based patient sample. Neurology 53(7), 1488-1494 (1999).
-
(1999)
Neurology
, vol.53
, Issue.7
, pp. 1488-1494
-
-
Andreasen, N.1
Minthon, L.2
Clarberg, A.3
-
186
-
-
0032821266
-
Longitudinal stability of CSF Tau levels in Alzheimer patients
-
Sunderland T, Wolozin B, Galasko D et al.: Longitudinal stability of CSF Tau levels in Alzheimer patients. Biol. Psychiatry 46(6), 750-755 (1999).
-
(1999)
Biol. Psychiatry
, vol.46
, Issue.6
, pp. 750-755
-
-
Sunderland, T.1
Wolozin, B.2
Galasko, D.3
-
187
-
-
34247893817
-
Longitudinal stability of CSF biomarkers in Alzheimer's disease
-
Blennow K, Zetterberg H, Minthon L et al.: Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci. Lett. 419(1), 18-22 (2007).
-
(2007)
Neurosci. Lett
, vol.419
, Issue.1
, pp. 18-22
-
-
Blennow, K.1
Zetterberg, H.2
Minthon, L.3
-
188
-
-
34547679856
-
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
-
Sanchez-Juan P, Sanchez-Valle R, Green A et al.: Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J. Neurol. 254(7), 901-906 (2007).
-
(2007)
J. Neurol
, vol.254
, Issue.7
, pp. 901-906
-
-
Sanchez-Juan, P.1
Sanchez-Valle, R.2
Green, A.3
-
189
-
-
0035910638
-
Transient increase in total Tau but not phospho-Tau in human cerebrospinal fluid after acute stroke
-
Hesse C, Rosengren L, Andreasen N et al.: Transient increase in total Tau but not phospho-Tau in human cerebrospinal fluid after acute stroke. Neurosci. Lett. 297(3), 187-190 (2001).
-
(2001)
Neurosci. Lett
, vol.297
, Issue.3
, pp. 187-190
-
-
Hesse, C.1
Rosengren, L.2
Andreasen, N.3
-
190
-
-
0034517797
-
Disease- and treatment-related elevation of the neurodegenerative marker Tau in children with hematological malignancies
-
Van Gool SW, Van Kerschaver E, Brock P et al.: Disease- and treatment-related elevation of the neurodegenerative marker Tau in children with hematological malignancies. Leukemia 14(12), 2076-2084 (2000).
-
(2000)
Leukemia
, vol.14
, Issue.12
, pp. 2076-2084
-
-
Van Gool, S.W.1
Van Kerschaver, E.2
Brock, P.3
-
191
-
-
18744417222
-
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors
-
Parnetti L, Amici S, Lanari A et al.: Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. Neurol. Sci. 23(Suppl. 2), S95-S96 (2002).
-
(2002)
Neurol. Sci
, vol.23
, Issue.SUPPL. 2
-
-
Parnetti, L.1
Amici, S.2
Lanari, A.3
-
192
-
-
34748915821
-
Reduction of phosphorylated Tau during memantine treatment of Alzheimer's disease
-
Degerman Gunnarsson M, Kilander L, Basun H, Lannfelt L: Reduction of phosphorylated Tau during memantine treatment of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 24(4), 247-252 (2007).
-
(2007)
Dement. Geriatr. Cogn. Disord
, vol.24
, Issue.4
, pp. 247-252
-
-
Degerman Gunnarsson, M.1
Kilander, L.2
Basun, H.3
Lannfelt, L.4
-
193
-
-
20944448555
-
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
-
Gilman S, Koller M, Black RS et al.: Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64(9), 1553-1562 (2005).
-
(2005)
Neurology
, vol.64
, Issue.9
, pp. 1553-1562
-
-
Gilman, S.1
Koller, M.2
Black, R.S.3
-
194
-
-
33847006236
-
Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid
-
Riekse RG, Li G, Petrie EC et al.: Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J. Alzheimers Dis. 10(4), 399-406 (2006).
-
(2006)
J. Alzheimers Dis
, vol.10
, Issue.4
, pp. 399-406
-
-
Riekse, R.G.1
Li, G.2
Petrie, E.C.3
-
195
-
-
15244363203
-
Association between Tau H2 haplotype and age at onset in frontotemporal dementia
-
Borroni B, Yancopoulou D, Tsutsui M et al.: Association between Tau H2 haplotype and age at onset in frontotemporal dementia. Arch. Neurol. 62(9), 1419-1422 (2005).
-
(2005)
Arch. Neurol
, vol.62
, Issue.9
, pp. 1419-1422
-
-
Borroni, B.1
Yancopoulou, D.2
Tsutsui, M.3
-
196
-
-
19944429064
-
Microtubule-binding drugs offset Tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model
-
Zhang B, Maiti A, Shively S et al.: Microtubule-binding drugs offset Tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl Acad. Sci. USA 102(1), 227-231 (2005).
-
(2005)
Proc. Natl Acad. Sci. USA
, vol.102
, Issue.1
, pp. 227-231
-
-
Zhang, B.1
Maiti, A.2
Shively, S.3
|